









市場行情
/
股票
/
nasdaq-enov
/

Enovis Corp

ENOV

26.840USD

+0.530+2.01%

收盤 12/24, 13:00（美東）報價延遲15分鐘

1.53B總市值

虧損本益比TTM



Enovis Corp

26.840

+0.530+2.01%

概覽公司財務分析

概覽

公司

財務

分析

關於 Enovis Corp 公司

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).

Enovis Corp簡介



公司代碼ENOV

公司名稱Enovis Corp

上市日期May 08, 2008

CEOMcdonald (Damien)

員工數量7367

證券類型Ordinary Share

年結日May 08

公司地址2711 Centerville Road

城市WILMINGTON

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編19808

電話13022529160

網址https://www.enovis.com/

公司代碼ENOV

上市日期May 08, 2008

CEOMcdonald (Damien)

Enovis Corp公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

114.51K

+9.57%

Mr. Damien Mcdonald

Chief Executive Officer, Director

102.75K

+6.71%

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-0.90%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

Ms. Barbara W. Bodem

Independent Director

10.52K

+168.36%

Dr. Christine Ortiz, Ph.D.

Independent Director

10.52K

+168.36%

Mr. Philip A. Okala

Independent Director

Ms. Angela S. Lalor

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Daniel Alexis Pryor

Executive Vice President - Strategy and Business Development

114.51K

+9.57%

Mr. Damien Mcdonald

Chief Executive Officer, Director

102.75K

+6.71%

Mr. Terry D. Ross

Group President - Prevention and Recovery

35.79K

-0.90%

Ms. Sharon L. Wienbar

Independent Chairman of the Board

28.26K

+30.46%

Mr. Rajiv Vinnakota

Independent Director

20.37K

+47.89%

Mr. Liam J. Kelly

Independent Director

15.27K

+76.12%

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

International Reconstructive

144.48M

25.59%

U.S. Reconstructive

129.49M

22.94%

U.S. Bracing & Support

120.85M

21.41%

International P&R

98.90M

17.52%

U.S. Other P&R

70.82M

12.55%

由於公司未披露，未能獲取相關數據

業務

地區

業務USD

名稱

營收

佔比

International Reconstructive

144.48M

25.59%

U.S. Reconstructive

129.49M

22.94%

U.S. Bracing & Support

120.85M

21.41%

International P&R

98.90M

17.52%

U.S. Other P&R

70.82M

12.55%

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.92%

The Vanguard Group, Inc.

11.35%

American Century Investment Management, Inc.

8.27%

Dimensional Fund Advisors, L.P.

5.20%

Davenport Asset Management

4.91%

其他

56.36%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

13.92%

The Vanguard Group, Inc.

11.35%

American Century Investment Management, Inc.

8.27%

Dimensional Fund Advisors, L.P.

5.20%

Davenport Asset Management

4.91%

其他

56.36%

股東類型

持股股東

佔比

Investment Advisor

63.50%

Investment Advisor/Hedge Fund

30.16%

Hedge Fund

16.30%

Research Firm

4.93%

Individual Investor

1.59%

Pension Fund

1.18%

Bank and Trust

1.18%

Family Office

0.07%

Sovereign Wealth Fund

0.05%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

617

68.12M

125.63%

2025Q3

641

68.12M

128.26%

-1.19M

2025Q2

651

69.44M

130.24%

+2.07M

2025Q1

629

67.38M

125.09%

-4.06M

2024Q4

625

63.48M

125.04%

+1.28M

2024Q3

599

62.09M

124.13%

-57.94K

2024Q2

602

61.71M

121.92%

+2.05M

2024Q1

635

59.58M

125.47%

-9.23M

2023Q4

647

58.62M

120.02%

+2.97M

2023Q3

636

55.66M

121.59%

+429.23K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

8.02M

14.03%

+1.50M

+22.95%

Jun 30, 2025

The Vanguard Group, Inc.

6.37M

11.14%

+288.04K

+4.74%

Jun 30, 2025

American Century Investment Management, Inc.

4.74M

8.29%

+1.21M

+34.39%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

2.92M

5.11%

-7.00K

-0.24%

Jun 30, 2025

Davenport Asset Management

2.76M

4.82%

-86.99K

-3.06%

Jul 31, 2025

Dorsey Asset Management LLC

2.55M

4.47%

+2.55M

Jun 30, 2025

State Street Investment Management (US)

2.49M

4.35%

+592.50K

+31.27%

Jun 30, 2025

Hood River Capital Management LLC

1.74M

3.04%

+292.95K

+20.31%

Jun 30, 2025

River Road Asset Management, LLC

1.44M

2.52%

+48.04K

+3.45%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

State Street SPDR S&P Health Care Equipment ETF

1.83%

Invesco S&P SmallCap Health Care ETF

1.09%

Invesco S&P SmallCap 600 Pure Value ETF

0.45%

State Street SPDR S&P 600 Small Cap Value ETF

0.25%

iShares S&P Small-Cap 600 Value ETF

0.24%

iShares U.S. Medical Devices ETF

0.21%

Humankind US Stock ETF

0.2%

State Street SPDR S&P SmallCap 600 ESG ETF

0.18%

Avantis US Small Cap Equity ETF

0.18%

Invesco S&P SmallCap 600 Revenue ETF

0.16%

State Street SPDR S&P Health Care Equipment ETF

佔比1.83%

Invesco S&P SmallCap Health Care ETF

佔比1.09%

Invesco S&P SmallCap 600 Pure Value ETF

佔比0.45%

State Street SPDR S&P 600 Small Cap Value ETF

佔比0.25%

iShares S&P Small-Cap 600 Value ETF

佔比0.24%

iShares U.S. Medical Devices ETF

佔比0.21%

Humankind US Stock ETF

佔比0.2%

State Street SPDR S&P SmallCap 600 ESG ETF

佔比0.18%

Avantis US Small Cap Equity ETF

佔比0.18%

Invesco S&P SmallCap 600 Revenue ETF

佔比0.16%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

公告日期

類型

比率

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

Mar 18, 2022

Merger

3→1

常見問題

Enovis Corp的前五大股東是誰？



Enovis Corp的前五大股東如下：
BlackRock Institutional Trust Company, N.A.
持有股份：8.02M
佔總股份比例：14.03%。
The Vanguard Group, Inc.
持有股份：6.37M
佔總股份比例：11.14%。
American Century Investment Management, Inc.
持有股份：4.74M
佔總股份比例：8.29%。
Dimensional Fund Advisors, L.P.
持有股份：2.92M
佔總股份比例：5.11%。
Davenport Asset Management
持有股份：2.76M
佔總股份比例：4.82%。